Intraoperative Methadone Use in Pediatric Burn Patients
Related Experiment Video
Updated: Oct 1, 2025

Anesthesia and Intubation of Preadolescent Mouse Pups for Cardiothoracic Surgery
Published on: June 2, 2022
Amanda Carlson1, David Pham2, Cayenne Price3
1Legacy Emmanuel Medical Center, Legacy Medical Group Trauma and General Surgery, Portland, Oregon, USA.
Insights
Intraoperative methadone may reduce opioid use in pediatric burn patients. This study found decreased postoperative opioid consumption with methadone, with no observed adverse events, suggesting potential benefits for pediatric burn pain management.
Area of Science:
- Pediatric Burn Care
- Pain Management
- Pharmacology
Background:
- Pediatric burn injuries result in significant physical and mental health issues.
- Opioids are standard for burn pain but raise concerns about dependence.
- Methadone, an N-methyl-D-aspartate (NMDA) and mu-opioid receptor agonist, is effective in adults but less studied in children.
Purpose of the Study:
- To compare postoperative opioid utilization in pediatric burn patients receiving intraoperative methadone versus those who did not.
- To assess methadone-related complications in this pediatric population.
Main Methods:
- Retrospective cohort study at a Level 1 Burn Center.
- Comparison of opioid utilization (mg/kg morphine equivalents) within 36 hours postoperatively.
- Chart review for methadone-related adverse events.
Main Results:
- The methadone cohort showed decreased opioid utilization (0.54 mg/kg) compared to the control cohort (0.77 mg/kg).
- No methadone-related adverse events were identified during chart review.
- Statistical significance for reduced opioid use was not reached (P = .18).
Conclusions:
- Methadone use appears beneficial in pediatric burn patients, potentially reducing overall opioid requirements.
- Further prospective studies in larger pediatric populations are needed to confirm efficacy and safety.
- Methadone may be a valuable adjunct in managing pediatric burn pain.
Abstract:
Burn injury in children can cause severe and chronic physical and mental sequelae. Opioids are a mainstay in burn pain management but increasing utilization in this country has led to concern for their continued use and potential for dependence. Methadone is a long-acting analgesic that targets the N-methyl-D-aspartate (NMDA) receptor in addition to the mu opioid receptor and has benefit in adult burn patients. However, its use in the pediatric burn population has been less robustly studied. This is a retrospective cohort study at a single Level 1 Burn Center whose primary aim is to compare opioid utilization 36 hours postoperatively between pediatric burn patients who received intraoperative, intravenous methadone and those who did not. Secondary aim was to describe differences in methadone-related complications between the cohorts. There was decreased opioid utilization measured by median morphine equivalents per kilogram (ME/kg) postoperatively in the methadone cohort compared to the control cohort (0.54 vs 0.77 mg/kg, P = .18). No adverse events were noted upon chart review. The data suggest that methadone use is beneficial in pediatric burn patients, but further prospective studies are warranted on a larger population.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Parenteral Anesthetics: Overview
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Delivery: Enteral Route

